类固醇与非类固醇矿物质皮质类受体对抗剂在心力衰竭与保存的喷射小部分:一个倾向匹配多网络全国队列研究
Talal Almas1, Mohamed Shelig2, Ahmed Al-Hindawi3
1Department of Internal Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.
European heart journal. Quality of care & clinical outcomes
|January 30, 2026
概括
与spironolactone相比,使用finerenone治疗心力衰竭与保留射出分数 (HFpEF) 的患者显著降低了心力衰竭恶化和死亡率. 这项研究强调了fineerenone.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 保持喷射分数 (HFpEF) 的心力衰竭对健康构成重大负担.
- 在HFpEF中,矿物质皮质类受体对抗剂 (MRA) 的疗效尚未完全被理解.
- 非类固醇MRA的Finerenone在减少HFpEF住院治疗方面表现有前途.
研究的目的:
- 为了在HFpEF患者中比较菲内伦与螺旋的现实有效性.
- 评估两种MRA之间的心力衰竭恶化,损伤和电解质失衡的比较风险.
主要方法:
- 使用TriNetX研究网络进行的回顾性观察队列研究.
- 1:1的倾向得分匹配,以创建可比的HFpEF患者组.
- 对关键临床结果的1年风险分析,包括心力衰竭恶化,急性损伤和死亡率.
主要成果:
- 与spironolactone相比,使用finerenone与心力衰竭恶化的风险显著降低 (HR 0.63),所有原因死亡率 (HR 0.38).
- 芬也显示了低血 (HR 0.58) 和急性损伤 (AKI) 的风险降低.
- 这些好处在由糖尿病 (DM) 和慢性病 (CKD) 分层的子组分析中是一致的.
结论:
- 在现实世界HFpEF队列中,finerenone在恶化和死亡率方面表现出比spironolactone更好的结果.
- 这些发现表明,finerenone可能是HFpEF管理的有价值的MRA选项.
- 需要通过随机对照试验进一步证实.
相关概念视频
01:29Heart Failure II: Pathophysiology
920
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
01:17Pathophysiology of Heart Failure
3.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
01:27Heart Failure I: Introduction
882
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
01:28Drug-Receptor Interaction: Antagonist
5.0K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
5.0K
01:22Heart Failure VI: Adjunct Therapies
336
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
01:22Heart Failure Drugs: Diuretics
966
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966